Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study
A. M. Nazief, Passainte S. Hassaan, Hoda M Khalifa, M. Sokar, A. El-Kamel
International Journal of Nanomedicine